122 related articles for article (PubMed ID: 35780928)
1. Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth.
Wang K; Wei J; Ma J; Jia Q; Liu Y; Chai J; Xu J; Xu T; Zhao D; Wang Y; Yan Q; Guo S; Guo X; Zhu F; Fan L; Li M; Wang Z
Cancer Lett; 2022 Sep; 544():215812. PubMed ID: 35780928
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon.
Xiao J; Duan Q; Wang Z; Yan W; Sun H; Xue P; Fan X; Zeng X; Chen J; Shao C; Zhu F
Oncotarget; 2016 Apr; 7(17):24483-94. PubMed ID: 27016416
[TBL] [Abstract][Full Text] [Related]
3. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
[TBL] [Abstract][Full Text] [Related]
4. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
Diao X; Yang D; Chen Y; Liu W
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
[TBL] [Abstract][Full Text] [Related]
5. TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.
Sun H; Zheng J; Xiao J; Yue J; Shi Z; Xuan Z; Chen C; Zhao Y; Tang W; Ye S; Li J; Deng Q; Zhang L; Zhu F; Shao C
Cell Death Dis; 2022 May; 13(5):450. PubMed ID: 35546143
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells.
Nandi A; Tidwell M; Karp J; Rapoport AP
Blood Cells Mol Dis; 2004; 32(1):240-5. PubMed ID: 14757441
[TBL] [Abstract][Full Text] [Related]
7. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
[TBL] [Abstract][Full Text] [Related]
8. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.
Zykova TA; Zhu F; Lu C; Higgins L; Tatsumi Y; Abe Y; Bode AM; Dong Z
Clin Cancer Res; 2006 Dec; 12(23):6884-93. PubMed ID: 17145805
[TBL] [Abstract][Full Text] [Related]
10. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
[TBL] [Abstract][Full Text] [Related]
11. PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.
Zhu K; Cheng X; Wang S; Zhang H; Zhang Y; Wang X; Chen Y; Wu J
Front Endocrinol (Lausanne); 2021; 12():706909. PubMed ID: 35126305
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
[TBL] [Abstract][Full Text] [Related]
13. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
[TBL] [Abstract][Full Text] [Related]
14. Novel biomarker, phosphorylated T-LAK cell-originated protein kinase (p-TOPK) can predict outcome in primary central nervous system lymphoma.
Koh M; Hayakawa Y; Akai T; Hayashi T; Tomita T; Nagai S; Kuroda S
Neuropathology; 2018 Jun; 38(3):228-236. PubMed ID: 29575092
[TBL] [Abstract][Full Text] [Related]
15. FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer.
Peng S; Yin Y; Zhang Y; Zhu F; Yang G; Fu Y
J Exp Clin Cancer Res; 2023 Apr; 42(1):80. PubMed ID: 37016377
[TBL] [Abstract][Full Text] [Related]
16. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.
Simons-Evelyn M; Bailey-Dell K; Toretsky JA; Ross DD; Fenton R; Kalvakolanu D; Rapoport AP
Blood Cells Mol Dis; 2001; 27(5):825-9. PubMed ID: 11783945
[TBL] [Abstract][Full Text] [Related]
17. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
[TBL] [Abstract][Full Text] [Related]
18. [Cyanidin-3-O-glucoside inhibits proliferation of colorectal cancer cells by targeting TOPK].
Wang L; Liu F; Liu Y; Gao H; Dong M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1101-1108. PubMed ID: 31894009
[TBL] [Abstract][Full Text] [Related]
19. Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase.
Zhao S; Cui J; Cao L; Han K; Ma X; Chen H; Yin S; Zhao C; Ma C; Hu H
Phytother Res; 2023 Jul; 37(7):3057-3068. PubMed ID: 36882184
[TBL] [Abstract][Full Text] [Related]
20. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.
Xue P; Wang Y; Zeng F; Xiu R; Chen J; Guo J; Yuan P; Liu L; Xiao J; Lu H; Wu D; Pan H; Lu M; Zhu F; Shi F; Duan Q
Oncotarget; 2017 Apr; 8(16):27093-27104. PubMed ID: 28404919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]